Features of Pathogenesis of Human Viral Infections and Antiviral Drugs

Among infectious diseases, viral infections are the leading cause of death worldwide, especially in the most low-income countries, particularly in young children. Most of the human viruses are all well characterized in terms of structure, life-cycle, tropism, and associated primary pathologies, but...

Full description

Saved in:
Bibliographic Details
Other Authors: Aquaro, Stefano (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_68341
005 20210501
003 oapen
006 m o d
007 cr|mn|---annan
008 20210501s2021 xx |||||o ||| 0|eng d
020 |a books978-3-03943-918-8 
020 |a 9783039439171 
020 |a 9783039439188 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03943-918-8  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Aquaro, Stefano  |4 edt 
700 1 |a Aquaro, Stefano  |4 oth 
245 1 0 |a Features of Pathogenesis of Human Viral Infections and Antiviral Drugs 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (84 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Among infectious diseases, viral infections are the leading cause of death worldwide, especially in the most low-income countries, particularly in young children. Most of the human viruses are all well characterized in terms of structure, life-cycle, tropism, and associated primary pathologies, but many of the pathogenetic mechanisms underlying their ability to cause acute infection, persist or reactivate in the host and cause chronic and/or degenerative damage, and still need to be fully clarified. At the same time, it seems necessary to develop novel therapeutic approaches and rationale, and possibly more potent antiviral compounds that are addressed to novel targets. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a hRSV 
653 |a F gene 
653 |a G gene 
653 |a children 
653 |a respiratory diseases 
653 |a genotyping 
653 |a Saudi Arabia 
653 |a α chemokine receptor 4 
653 |a β-chemokine receptor 5 
653 |a human immunodeficiency virus 
653 |a monocyte-derived macrophages 
653 |a HPV 
653 |a sexually transmitted diseases (STDs) 
653 |a laboratory methods 
653 |a PCR 
653 |a genotypes 
653 |a surveillance 
653 |a epidemiology 
653 |a exopolysaccharides 
653 |a lactic acid bacteria 
653 |a human adenovirus type 5 
653 |a antiviral activity 
653 |a cell cycle 
653 |a prevalence 
653 |a hepatitis B virus 
653 |a genotype 
653 |a bahrain 
653 |a sRAGE 
653 |a oxidative stress 
653 |a inflammation 
653 |a warts 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/3351  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/68341  |7 0  |z DOAB: description of the publication